These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5429066)
1. [The lying advertisement of pharmaceuticals]. Dillemann G; Plat M Ann Pharm Fr; 1970 Mar; 28(3):223-33. PubMed ID: 5429066 [No Abstract] [Full Text] [Related]
2. [Parapharmaceutical advertising and its control (law no. 72-7 of 3 January 1972)]. Doll PJ Med Leg Dommage Corpor; 1972; 5(4):359-62. PubMed ID: 4679040 [No Abstract] [Full Text] [Related]
3. [Away with quacks. Law no. 72-7 of 3 January 1972]. Doll PJ Nouv Presse Med; 1972 Jan; 1(5):353-4. PubMed ID: 4334558 [No Abstract] [Full Text] [Related]
4. [Ethics of medical advertising]. de Oliveira E Hospital (Rio J); 1969 Oct; 76(4):1385-94. PubMed ID: 5308117 [No Abstract] [Full Text] [Related]
5. [Rules for the advertising of special preparations? Suggestion for a safe standardization]. Naess K Tidsskr Nor Laegeforen; 1968 Mar; 88(5):347-9. PubMed ID: 5671518 [No Abstract] [Full Text] [Related]
6. [Archeology of the radio pharmaceutical advertisement]. Lefebvre T Rev Hist Pharm (Paris); 2002; 50(336):647-65. PubMed ID: 12731488 [TBL] [Abstract][Full Text] [Related]
7. The great chain of buying: medical advertisement, the bourgeois public sphere, and the origins of the French Revolution. Jones C Am Hist Rev; 1996 Feb; 101(1):13-40. PubMed ID: 11609106 [No Abstract] [Full Text] [Related]
9. The economic wisdom of regulating pharmaceutical "freebies". Fisher SH Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416 [No Abstract] [Full Text] [Related]
10. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns]. Cianciara D Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020 [TBL] [Abstract][Full Text] [Related]
11. [Comparative advertising and medicine: changing of regulations]. Chrétienne M Ann Pharm Fr; 1999 Jul; 57(4):350-4. PubMed ID: 10472708 [TBL] [Abstract][Full Text] [Related]
12. Regulation of online pharmacy: an Australian perspective. Bernath P J Law Med; 2003 Feb; 10(3):339-63. PubMed ID: 12650004 [TBL] [Abstract][Full Text] [Related]
13. Decree No. 87-772, 23 September 1987. France Annu Rev Popul Law; 1987; 14():20. PubMed ID: 12346647 [TBL] [Abstract][Full Text] [Related]
14. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium. Garbutt BJ; Hofmann ME Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558 [No Abstract] [Full Text] [Related]
15. [Limits of drug advertisement with scientific works]. Reichert K Ther Ggw; 1970 Feb; 109(2):272 passim. PubMed ID: 5441698 [No Abstract] [Full Text] [Related]
16. A defense of the learned intermediary doctrine. Goetz RB; Growdon KR Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470 [No Abstract] [Full Text] [Related]
17. Television advertisement format and the provision of risk information about prescription drug products. Glinert LH; Schommer JC Res Social Adm Pharm; 2005 Jun; 1(2):185-210. PubMed ID: 17138474 [TBL] [Abstract][Full Text] [Related]
18. Medicines (Advertisement and Sale) (Amendment) Act, 1968. Leng GA Singapore Med J; 1969 Mar; 10(1):1. PubMed ID: 5803556 [No Abstract] [Full Text] [Related]
20. [The "responsible pharmacist" in Europe: is there a French exception?]. Chalchat B Ann Pharm Fr; 2002 Sep; 60(5):352-5. PubMed ID: 12378147 [No Abstract] [Full Text] [Related] [Next] [New Search]